[144] ParaZero Technologies Ltd. SEC Filing

Rhea-AI Filing Summary

ParaZero Technologies Ltd. (PRZO) filing a Form 144 notifies the intended sale of 13,983 ordinary shares through Oppenheimer & Co. on Nasdaq with an aggregate market value of $18,457.56. The shares were acquired as restricted stock units (RSU) on 02/19/2025 and payment or settlement occurred the same day. The filing reports 12,817,092 shares outstanding and indicates no securities sold by the reporting person in the past three months. The filer certifies there is no undisclosed material adverse information and includes the standard attestation regarding trading plans and Rule 10b5-1.

Insights

Securities Analyst

TL;DR: Insider plans a routine sale of RSU shares acquired earlier in the year; disclosure appears procedural and non-material.

The Form 144 shows a proposed sale of 13,983 ordinary shares with an aggregate value of $18,457.56 through a broker on Nasdaq. The shares originated from an RSU grant on 02/19/2025 and were settled the same day. No other sales by the reporting person were disclosed for the prior three months and the filer provides the required attestation about material information and potential 10b5-1 plans. Given the reported size relative to the listed outstanding shares, this appears to be a standard insider liquidity event rather than a company-level development.

Corporate Governance Expert

TL;DR: Filing meets Rule 144 disclosure requirements; signatures and attestations are present but no governance change is reported.

The notice includes the necessary Rule 144 details: class of security, broker, quantity, market value, acquisition date and nature (RSU), and outstanding share count. The submission contains the statutory attestation about knowledge of material adverse information and references trading plan considerations. There is no indication of executive departure, related-party transactions, or material governance actions in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. 85 Broad st. New York NY 10004	13983	18457.56	12817092	09/08/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	02/19/2025	RSU	Issuer			13983	02/19/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ParaZero Technologies' Form 144 for PRZO disclose?

The filing discloses a proposed sale of 13,983 ordinary shares via Oppenheimer & Co. on Nasdaq, with aggregate market value $18,457.56.

When were the shares in the Form 144 acquired?

The shares were acquired as RSUs on 02/19/2025 and the filing shows payment/settlement dated 02/19/2025.

How many ParaZero shares are outstanding according to the filing?

The filing reports 12,817,092 shares outstanding for the issuer.

Did the filer sell any PRZO securities in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Does the Form 144 include an attestation about material information or a trading plan?

Yes. The filer represents they do not know any undisclosed material adverse information and references the representation tied to any Rule 10b5-1 trading plan adoption date.